Search Count: 70
![]() |
Seryl-Trna Synthetase In Complex With A Fragment-Sized Inhibitor (3-Cyclopropyl Benzoic Acid)
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2026-06-24 Classification: LIGASE Ligands: A1J8R, GOL |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION
Release Date: 2026-06-24
Ligands: A1J8R, GOL
![]() |
Human Carbonic Anhydrase I Covalently Bound To Av21-08
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.39 Å Release Date: 2024-12-18 Classification: LYASE Ligands: ZN, PPI, TRS, DMS, EDO, VV8, ACY |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-12-18
Ligands: ZN, PPI, TRS, DMS, EDO, VV8, ACY
![]() |
Three-Dimensional Structure Of Human Carbonic Anhydrase Ix In Complex With A Covalent Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2024-12-18 Classification: LYASE Ligands: ZN, A1IDV |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-12-18
Ligands: ZN, A1IDV
![]() |
Three-Dimensional Structure Of Human Carbonic Anhydrase Ii In Complex With A Covalent Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2024-04-10 Classification: LYASE Ligands: ZN, VV8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-04-10
Ligands: ZN, VV8
![]() |
Crystal Structure Of Mjf14-6-4-2 Fab Fragment In Complex With Epitope Peptide
Organism: Oryctolagus cuniculus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.71 Å Release Date: 2024-03-27 Classification: IMMUNE SYSTEM |
Organism: Oryctolagus cuniculus, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2024-03-27
![]() |
Pseudomonas Aeruginosa Fabf C164A In Complex With 3-Amino-N-(1,5-Dimethyl-3-Oxo-2-Phenyl-2,3-Dihydro-1H-Pyrazol-4-Yl)Benzamide
Organism: Pseudomonas aeruginosa
Method: X-RAY DIFFRACTION Resolution:1.51 Å Release Date: 2024-03-06 Classification: TRANSFERASE Ligands: FMT, XG7, EDO, DMS |
Organism: Pseudomonas aeruginosa
Method: X-RAY DIFFRACTION
Release Date: 2024-03-06
Ligands: FMT, XG7, EDO, DMS
![]() |
Pseudomonas Aeruginosa Fabf C164A In Complex With N-(1,5-Dimethyl-3-Oxo-2-Phenyl-2,3-Dihydro-1H-Pyrazol-4-Yl)-2-(4-Methoxyphenoxy)Acetamide
Organism: Pseudomonas aeruginosa
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2024-03-06 Classification: TRANSFERASE Ligands: XJR, DMS, FMT |
Organism: Pseudomonas aeruginosa
Method: X-RAY DIFFRACTION
Release Date: 2024-03-06
Ligands: XJR, DMS, FMT
![]() |
Pseudomonas Aeruginosa Fabf C164A Mutant In Complex With N-(1,5-Dimethyl-3-Oxo-2-Phenyl-2,3-Dihydro-1H-Pyrazol-4-Yl)-3-Methylbutanamide
Organism: Pseudomonas aeruginosa
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-02-21 Classification: TRANSFERASE Ligands: DMS, FMT, ZHX |
Organism: Pseudomonas aeruginosa
Method: X-RAY DIFFRACTION
Release Date: 2024-02-21
Ligands: DMS, FMT, ZHX
![]() |
Sars-Cov-2 Nsp16-Nsp10 In Complex With Sam Derivative Inhibitor 11
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2024-02-21 Classification: VIRAL PROTEIN Ligands: MES, A1H4D, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-21
Ligands: MES, A1H4D, ZN
![]() |
Sars-Cov-2 Nsp16-Nsp10 In Complex With Sam Derivative Inhibitor 9
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2024-02-21 Classification: VIRAL PROTEIN Ligands: A1H4C, MES, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-21
Ligands: A1H4C, MES, ZN
![]() |
Sars-Cov-2 Nsp16-Nsp10 In Complex With Sam Derivative Inhibitor 10
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2024-02-21 Classification: VIRAL PROTEIN Ligands: A1H4B, MES, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-21
Ligands: A1H4B, MES, ZN
![]() |
Sars-Cov-2 Nsp16-Nsp10 In Complex With Sam Derivative Inhibitor 2
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: MES, A1H3C, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-14
Ligands: MES, A1H3C, ZN
![]() |
Sars-Cov-2 Nsp16-Nsp10 In Complex With Sam Derivative Inhibitor 1
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: MES, MTA, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-14
Ligands: MES, MTA, ZN
![]() |
Sars-Cov-2 Nsp16-Nsp10 In Complex With Sam Derivative Inhibitor 2
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: MES, A1H3B, GOL, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-14
Ligands: MES, A1H3B, GOL, ZN
![]() |
Sars-Cov-2 Nsp16-Nsp10 In Complex With Sam Derivative Inhibitor 4
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: MES, A1H3E, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-14
Ligands: MES, A1H3E, ZN
![]() |
Sars-Cov-2 Nsp16-Nsp10 In Complex With Sam Derivative Inhibitor 5
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: MES, A1H28, GOL, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-14
Ligands: MES, A1H28, GOL, ZN
![]() |
Sars-Cov-2 Nsp16-Nsp10 In Complex With Sam Derivative Inhibitor 6
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: MES, A1H3A, GOL, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-14
Ligands: MES, A1H3A, GOL, ZN
![]() |
Sars-Cov-2 Nsp16-Nsp10 In Complex With Sam Derivative Inhibitor 7
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: MES, A1H3D, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-14
Ligands: MES, A1H3D, ZN
![]() |
Sars-Cov-2 Nsp16-Nsp10 In Complex With Sam Derivative Inhibitor 8
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2024-02-14 Classification: VIRAL PROTEIN Ligands: MES, A1H29, ZN |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2024-02-14
Ligands: MES, A1H29, ZN
![]() |
Crystal Structure Of Bacterial Prolyl Peptidyl Isomerase With 5,5'-Difluoroleucines
Organism: Escherichia coli (strain k12)
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2022-11-16 Classification: ISOMERASE Ligands: SO4 |
Organism: Escherichia coli (strain k12)
Method: X-RAY DIFFRACTION
Release Date: 2022-11-16
Ligands: SO4
